Gini Fleming to Drug Monitoring
This is a "connection" page, showing publications Gini Fleming has written about Drug Monitoring.
Connection Strength
0.145
-
A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. Clin Cancer Res. 2018 05 15; 24(10):2285-2293.
Score: 0.145